ARTICLE | Company News
Bayer gets Priority Review for Algeta's radium-223
February 14, 2013 2:12 AM UTC
Bayer AG (Xetra:BAYN) said FDA accepted and granted Priority Review to an NDA for radium-223 dichloride (formerly Alpharadin) to treat castration-resistant prostate cancer (CRPC) in patients with bone...